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s u m m a r y
Despite abundant evidence that neutrophils arrive early at sites of mycobacterial disease and phagocy-
tose organisms, techniques to assay phagocytosis or killing of mycobacteria by these cells are lacking.
Existing assays for measuring the antimycobacterial activity of human leukocytes require cell lysis which
introduces new bioactive substances and may be incomplete. They are also time-consuming and carry
multiple risks of inaccuracy due to serial dilution and organism clumping. Flow cytometric techniques for
measuring phagocytosis of mycobacteria by human cells have failed to adequately address the effects of
organism clumping, quenching agents and culture conditions on readouts.
Here we present a novel in-tube bioluminescence-based assay of antimycobacterial activity by human
neutrophils. The assay yields intuitive results, with improving restriction of mycobacterial biolumines-
cence as the ratio of cells to organisms increases. We show that lysis of human cells is not required to
measure luminescence accurately.
We also present a phagocytosis assay inwhichwe haveminimised the impact ofmycobacterial clumping,
investigated the effect of various opsonisation techniques and established the correct usage of trypanblue to
identify surface-bound organismswithout countingdead cells. The samemultiplicity of infection and serum
conditions are optimal to demonstrate both internalisation and restriction of mycobacterial growth.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Tuberculosis is a major threat to humanity, but the host
response to Mycobacterium tuberculosis remains incompletely
understood. The role of neutrophils is particularly controversial, as
these cells may contribute to both protection and pathology.1,2 It
has been proposed that control of mycobacteria by neutrophils,
especially virulent M. tuberculosis, demonstrates inter-individual
variability,3 which may help to explain inter-individual differ-
ences in the ability of the innate immune system to control
infection or dissemination, as well as differences in reported
experimental results.3,4 However, techniques to assess growth
restriction by human neutrophils are not well established. Assess-
ment of neutrophil antimycobacterial activity using a classical
colony-forming unit (CFU) assay has multiple limitations. First, cell-
pathogen cultures are necessarily disturbed in the process of
pathogen enumeration. Cell lysis to release organisms introduces
new bio-active reagents and may be incomplete. Serial dilutions
before plating CFU may be inaccurate, due to clumping and pipet-
ting error, and the process is time-consuming. Furthermore, exist-
ing techniques for mycobacterial quantiﬁcation (including
radiometric assays such as Bactec) require prolonged culture of
organisms in growth medium after the end of the restriction assay.
This not only increases the risk of contamination and represents
a safety issue for the laboratory but also deviates the in vitro assay
further from in vivo reality, where organisms would not have the
opportunity to recover and replicate in the absence of immune
challenge.
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Another crucial aspect of host leucocyte function in addition to
killing is phagocytosis of mycobacteria: this is either a prerequisite
for elimination of the organisms or an essential stage in dissemi-
nating viable organisms to distant sites. However, assessment of
this process is also challenging. Flow cytometric techniques5e10
avoid labour-intensive microscopy but suffer a number of poten-
tial pitfalls. Speciﬁcally, it has been little appreciated that vital dyes
such as trypan blue, used to ‘quench’ extracellular ﬂuorescence and
to identify surface-bound organisms, also stain dead cells and will
enter ﬁxed cells.7 Furthermore, mycobacterial clumping in culture
can signiﬁcantly interfere with ﬂow cytometry assays.6 Although
various techniques can minimise this at the point of inoculation,
the organisms tend to re-aggregate during incubation.6
Here we describe a novel, luminescence-based, in-tube assay of
antimycobacterial activity for human neutrophils infected with
either Mycobacterium bovis BCG (BCG) or M. tuberculosis (M. tb)
together with a ﬂow cytometric phagocytosis assay. These assays
utilise mycobacteria whose bioluminescence is conferred by
a plasmid encoding the AB segment of the Vibrio harveyi lux operon,
as previously described.11 Light is emitted after addition of
a substrate (1% n-decylaldehyde in ethanol), and this adenosine
triphosphate (ATP)-dependent process reﬂects the metabolic
activity of the organisms. Of note, transformationwith this plasmid
does not appear to negatively impact bacterial ﬁtness or virulence,
as previously demonstrated in an animal model.11
2. Materials and methods
2.1. Organisms and labelling
The plasmid construction and electroporation of organisms has
been described previously.11 1.5 ml vials of mycobacteria stored
at 80 C were defrosted and added to 15 mls (M. tb) or 20 mls
(BCG) liquid 7H9 (Becton Dickinson)/ADC (Becton Dickinson)
growth medium enriched with 0.05% Tween 80 (Sigma) and 1 mcl/
ml hygromycin B (Roche diagnostics). Organisms were grown to
mid-log phase (72 h) before use in these assays.
For Fluorescein isothiocyanate (FITC) labelling, 5 ml of mid-log
phase organisms in 7H9 were centrifuged at 2000  g for 5 min
and resuspended in 1 ml carbonate-bicarbonate buffer (pH 9.6)
containing 0.05% Tween 80. 5 mcl of FITC stock (Sigma), previously
made to 100 mg/ml with Dimethyl sulfoxide (DMSO) and stored
at20 C until use, was added and the suspensionwas incubated at
37 C for 15 min. The labelled organisms were spun in a micro-
centrifuge at 4000  g for 2 min, the supernatant was aspirated
and the pellet was resuspended in 1 ml Phosphate Buffered Saline
(PBS) containing 0.05% Tween 80. This washing step was repeated
twice and the organisms were then resuspended in 7H9.
Luminescence of stock was measured in a Berthold AutoLumat
LB953 luminometer (for BCG) or in a Berthold Sirius single-tube
luminometer (for M. tb, inside a Biosafety Cabinet) on duplicate
samples of 100mcl organisms added to 900mcl PBS in 5ml test tubes
(Becton Dickinson). Both luminometers automatically inject 100 mcl
of the substrate 1% n-decylaldehyde (Sigma) in ethanol.
The relative light unit (RLU) to colony forming unit (CFU) ratio
for both stocks (established by contemporaneous RLU measure-
ment and plating for CFU of mycobacteria growing in 7H9medium)
was determined to be approximately 3:1. Organisms were diluted
in a standard volume of PBS to reach the required number of RLU
for the experiments.
2.2. Neutrophil isolation
Human neutrophils were isolated either by magnetic beads or
Percoll gradient from the peripheral blood of healthy consenting
donors. For bead separation 4 ml freshly drawn heparinised blood
was incubated for 15 min with 200 mcl magnetic human CD15
MicroBeads (Miltenyi Biotec) at 4 C.During this time anLS column in
aMidiMACS separation unit (Miltenyi Biotec) was ‘primed’ with 3ml
MACSbuffer (0.5% bovine serumalbuminþ 20mMEthylene diamine
tetra acetic acid (EDTA) in PBS). After incubationwith beads the blood
was diluted 1:1 with Roswell Park Memorial Institute-1640 medium
(RPMI-1640) and pipetted onto the top of the LS column.
Once the blood had percolated through the column, 6 ml RPMI-
1640 was added to wash out residual erythrocytes and loosely
adherent cells. The columnwas then removed from the magnet and
placed into a 15ml Falcon tube, 2ml RPMI-1640was added to the top
and plunged briskly through the column using the supplied syringe
driver. The collected CD15 þ cells were counted using a Beckman
Coulter Ac.T Diff haematology analyser and diluted if necessary with
further RPMI-1640 to reach the required ﬁnal concentration.
For Percoll isolation, 30 ml heparinised blood was sedimented
using 4 ml 6% Dextran (Sigma). The leucocyte-rich upper layer was
then aspirated, transferred to a new 50 ml Falcon tube and
centrifuged at 350 g for 6 min. Pelleted cells were resuspended in
3 ml 55% Percoll and layered onto a discontinuous gradient of 3 ml
81% Percoll and 3 ml 70% Percoll. The gradient was centrifuged at
700  g for 20 min with no deceleration. Granulocytes were har-
vested from the 71/80 interface.12,13 Both techniques consistently
yield >95% purity granulocytes by Coulter counting.
2.3. Serum generation, inactivation and pre-opsonisation
Freshly drawn non-anticoagulated blood was centrifuged in
a 15 ml Falcon tube at 500  g for 15 min with minimal decelera-
tion. Separated plasma was transferred to another Falcon tube and
incubated in a water bath at 37 C. After the platelets had plugged
serum was aspirated for use.
Heat inactivation of serum was performed in a water bath at
56 C for 30 min or at 90 C for 2 min, as indicated. Heat inactivated
fetal calf serumwas obtained from Biochrom AG (Berlin, Germany).
For pre-opsonisation, 200 mcl BCG-lux suspension in 7H9 at
a concentration of 5 million RLU (1.7 million CFU)/100 mcl was incu-
bated at a 1:1 volume ratiowith autologous serum for 20minat 37 C.
2.4. Mycobacterial restriction assay
Granulocytes were resuspended to an appropriate concentration
(usually1106 cells/ml) inRPMI-1640.400mclof cell suspensionwas
pipetted into a 5 ml Falcon ﬂow cytometry tube (Becton Dickinson).
50 mcl autologous serumwas added (giving a ﬁnal concentration of
10% serum) followed by 50 mcl organism suspension, appropriately
diluted to reach the requiredmultiplicity of infection (MOI). The tubes
were capped and then rolled to ensure that all organismsweremixed
with the cell suspension before being incubated on their sides on
a rocking plate (20 revolutions per minute (rpm)) at 37 C. After the
required time had elapsed, samples were allowed to cool to room
temperature for ﬁve minutes (V. harveyi luciferase-induced lumines-
cence is maximal at room temperature and relatively inhibited at
37 C14), brieﬂy vortexed, caps were removed and the tubes were
placed in a luminometer for measurement.
2.5. Lysis
To lyse human cells, 1 ml 0.1% Saponinwas added, samples were
vortexed, incubated for 30 min and vortexed again. 1 ml PBS was
added to control samples, which were otherwise treated identi-
cally. Permeabilisation was conﬁrmed by microscopy of cells
stained with trypan blue and by ﬂow cytometry after addition of
propidium iodide (see below).
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2.6. Phagocytosis assay
500 mcl of CD15-positive granulocytes in RPMI-1640 at
a concentration of 1  106/ml were aliquotted into sterile 5 ml
ﬂow cytometry tubes. A suspension of organisms (pre-opsonised
with autologous serum or non-opsonised) was added at an
appropriate volume to reach the required MOI for the relevant
experiment. The MOIs investigated, expressed as RLU:cells, were
10:1, 1:1, 1:2 and 1:10. These MOIs approximately equate to
CFU:cell ratios of 3:1, 1:3, 1:6 and 1:30 respectively. Non-pre-
opsonised samples had serum (or PBS in serum-free experi-
ments) added at the same time as organisms and ﬁnal volumes
were adjusted with relevant media to ensure comparability of
conditions.
Samples were capped and then rolled to ensure that all organ-
isms were mixed with the cell suspension before being incubated
on their sides on a rocking plate (20 rpm) at 37 C for 30 min.
During this time the centrifuge was cooled to 0 C. After 30 min
samples were placed immediately on ice for 5 min and then spun at
300  g for 5 min in the pre-chilled centrifuge. Samples were
returned to ice and supernatants were aspirated, leaving approxi-
mately 100 mcl volume. 1 mcl eFluor450 Fixable Viability Dye
(eBiosciences) and 0.5 mcl Phycoerythrin (PE)-conjugated anti-
CD66a, c, e antibody was added to the pellets and samples were
incubated for 12 min. Subsequently 1 ml of ice-cold PBS and
12.5 mcl of 0.2 micron syringe-ﬁltered Trypan blue (Sigma) was
added to the tubes and theywere transferred back to the centrifuge
at 0 C. (Note that syringe ﬁltering of trypan blue is required
because it becomes highly particulate in suspension and can
interfere with ﬂow cytometry.) After a further centrifuge spin at
300 g for 5min, supernatants were aspirated and the pellets were
resuspended in 500 mcl 2% paraformaldehyde (BCG) or 4% para-
formaldehyde (M. tb).
2.7. Flow cytometry
Flow cytometry was performed immediately (BCG samples) or
the following day on a Becton Dickinson Fortessa machine. Voltages
were used as follows: Forward Scatter (FSC) (Height & Area) ¼ 280,
Side Scatter (SSC) ¼ 258, Allophycocyanin (APC) ¼ 604, Paciﬁc
Blue ¼ 467, Alexa Fluor 488 ¼ 511, PE ¼ 450. The threshold set on
Forward Scatter Area was 24,667. A total of 50,000 events were
collected for each cell sample.
2.8. Assessment of clumping
To assess the extent of clumping of mycobacteria in the
phagocytosis experiments, parallel samples were processed
without human cells. Volumes of organisms and serum were
identical, but 500mcl RPMI-1640 was used instead of a granulocyte
suspension. The samples were acquired on the ﬂow cytometer for
the maximum duration taken by a contemporaneous cell sample to
reach 50,000 events.
2.9. Compensation controls
An identically processed aliquot of uninfected cells and serum
was stained with CD66a, c, e-PE alone. Another aliquot of cells was
divided into two and one half was heat-shocked at 60 C in a water
bath for 20 min. The two halves were then recombined, mixed and
separated into two again. One of these was labelled with eFluor450
Fixable Viability Dye and the other with trypan blue. A further
sample of granulocytes contained organisms only with no dyes or
ﬂuorochromes and a ﬁnal control contained neither organisms nor
ﬂuorescent molecules.
2.10. Analysis
Analysis was performed with FlowJo software Version 7.6.1
(Treestar). Compensation parameters were derived from the single
stained and unstained samples and applied to the experimental
samples. To analyse experimental samples, ﬁrst doublet signals
were excluded by plotting Forward Scatter Area versus Forward
Scatter Height. Subsequently dead cells were excluded on a plot of
eFluor450 Viability Dye versus APC (trypan blue signal). Neutro-
phils were then gated within the live cells as CD66a, c, e-PE
positive events with high side scatter. These were divided into
quadrants by plotting FITC versus APC (emission spectrum of
trypan blue).
2.11. Confocal microscopy
Samples were incubated using the same reagent quantities as
described above in 8-chambered coverslips (Lab-Tek) and images
were obtained on live cells using a Zeiss Axiovert LSM 510 Meta
NLO Confocal Microscope. Nuclei were stained using themembrane
permeable dye Hoechst 33342 (Anaspec). Some experiments were
undertaken using Green Fluorescent Protein (GFP)-expressing BCG-
lux organisms, inwhich GFP is encoded on the same plasmid as the
lux AB. Image z-stacks were acquired using the 488 nm laser line at
5% transmission for excitation of GFP and differential interference
contrast, and two-photon excitation of Hoechst 33342 with
a Spectra-Physics MaiTai DeepSee laser set to 1% transmission at
750 nm. GFP/FITC ﬂuorescence was detected using a 505e530 nm,
and Hoechst 33342 with a 420e460 nm bandpass ﬁlter. Image z-
stacks were rendered into orthogonal projections to demonstrate
internalization of BCG.
2.12. Statistics
Comparison of two groups was performed by two-tailed paired
Student’s t-test. Comparison of several groups was performed by
one-way analysis of variance (ANOVA) with post-hoc Bonferroni
correction for parametric data or by KruskaleWallis test with post-
hoc Dunn’s correction for non-parametric data. All statistics were
performed using GraphPad Prism Version 4.00.
3. Results
3.1. Neutrophils restrict bioluminescence of BCG-lux and M. tb-lux
in a dose-dependent manner
Isolated neutrophils from nine donors were infectedwith a ﬁxed
inoculum of BCG-lux across a variety of neutrophil numbers.
Luminescence measured at one hour post-inoculation showed
a clear negative correlation with the number of neutrophils
(Figure 1a). We repeated the experiment using six separate donors
and a higher ratio of neutrophils to organisms: this demonstrated
a greater reduction in recovered luminescence than was seen at
higher MOI (Figure 1b). The degree of suppression of biolumines-
cence using anMOI of 0.17 was similar forM. tb-lux (cell-containing
samples exhibited mean 57.8% [range 41.8%e87.3%] luminescence
of serum-only samples, see Figure 1c) and BCG-lux (cell-containing
samples exhibited mean 62.1% [range 32.7%e105.4%] luminescence
of serum-only samples, see Figure 1b). At 24 h, the ability of cells to
restrict mycobacterial luminescence versus serum was more
signiﬁcant than at one hour (Figure 1d), although interestingly
therewas relatively less effect at the highest MOI by this time point.
On the basis of these results we suggest that an MOI of approxi-
mately 1 CFU:3e6 cells is optimal to demonstrate an appreciable
cell effect and yield inter-individual variability. Of note, the
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Figure 1. Restriction of mycobacterial luminescence by neutrophils is inversely proportional to multiplicity of infection and requires viable cells. a. Luminescence of BCG-lux
(Relative Light Units, RLU) at one hour post-inoculation according to MOI. Column heights represent the mean results from nine separate donors (neutrophils isolated by
MicroBeads) performed in triplicate for each MOI; error bars indicate standard deviation (SD). The inoculumwas standardised to 200,000 RLU (80,000 CFU) and the number of cells
was varied as indicated. The serum control contained no neutrophils. Overall p-value for one-way ANOVA < 0.0001. b. Luminescence of BCG-lux using higher ratio of neutrophils to
organisms. Column heights represent the mean results from six different donors (neutrophils isolated by Percoll gradient) performed in triplicate for each donor; error bars indicate
SD. Other experimental conditions as in (a). c. Luminescence of M. tb-lux using same MOI as in (b). Column heights represent mean results from four separate donors (neutrophils
isolated by MicroBeads) performed in triplicate for each donor; error bars indicate SD. Other experimental conditions as in (a). d. 24 h luminescence readings from same
experiments presented in (a). Overall p-value for one-way ANOVA < 0.0001. e. and f. Luminescence of BCG-lux (200,000 RLU/80,000 CFU inoculum) incubated in RPMI-1640 with
either 10% serum only (‘Serum’), serum plus viable neutrophils at MOI 0.17:1 (‘Viable cells’) or serum plus neutrophils pre-heat-shocked at 60 C for 20 min at MOI 0.17:1 (‘Dead
cells’); luminescence was measured at 1 h (e) or 24 h (f). Markers represent the mean of triplicate readings per condition (3 donors).
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addition of dead (heat-shocked) neutrophils to mycobacteria had
no effect on mycobacterial bioluminescence at either 1 h or 24 h
(Figure 1e and f).
3.2. Lysis of neutrophils is not required in these experiments for
accurate measurement of antimycobacterial effects
Although the substrate for the lux construct is an aldehyde,
which would be expected to diffuse freely through cell
membranes,15 it could not be assumed that this would reach bacilli
inside the phagosome of viable neutrophils. It was important to
establish that the assay did indeed measure both intracellular
and extracellular bacilli, since neutrophil killing may occur
either inside or outside the cell. We thus proceeded to establish
whether neutrophil lysis inﬂuencedmeasurement of mycobacterial
bioluminescence, and hence accurate estimation of the anti-
mycobacterial effect of neutrophils, in these experiments. Lysis
using 0.1% saponin solution in PBS, which permeabilised all human
cells to propidium iodide (Figure 2a), did not have a different effect
on mycobacterial luminescence to the addition of PBS vehicle alone
(Figure 2b). An apparent increase in luminescence in both PBS and
saponin-treated samples largely occurred immediately, most likely
due to the increased volume (which perhaps increased the amount
of sample exposed to the luminometer’s light sensor). However, the
ratio of luminescence in samples containing cells to that in samples
containing serum alone was not inﬂuenced by the addition of
saponin solution vs. PBS vehicle control (Figure 2c). We therefore
maintained the assay volume at 500 mcl to ensure an adequate
density of neutrophils in the assay, which may be limited
depending on isolation method or blood volume. Plating for CFU of
lysed samples also revealed the same pattern as RLU data (Figure 2d
and e), suggesting that luminescence results indicating mycobac-
terial restriction by neutrophils are accurate. There was good
correlation between RLU and CFU: at 1 h Pearson r ¼ 0.88 (95% CI
0.46e0.98, p ¼ 0.004); at 24 h Pearson r ¼ 0.95 (95% CI 0.74e0.99,
p ¼ 0.0003).
We also investigated the time required to reach maximum lumi-
nescence in cell-containing and cell-free samples. Therewas a longer
delay before peak luminescence in the cell samples, consistent
with diffusion of the substrate across additional membranes
(Supplementary Figure 1a). Prolonged measurement times do not
‘close the gap’ between the cell samples and the serum-only samples,
suggesting that there is not a slow or delayed diffusion of substrate to
viable intra-cellular organisms (Supplementary Figure 1b). We
therefore conclude that 20 s is sufﬁcient measurement time.
Finally, the difference in luminescence between serum-only and
cell-containing samples persists to 24 h (Figure 1d), a time point
when most of the neutrophils have undergone cell death. In
experiments using BCG-lux with MOI of 1 CFU:3 cells, cell-
containing samples exhibited a mean of 81.6% (26.6%) of the
luminescence of corresponding serum-only samples by one hour
(across nine donors). At 24 h this ﬁgure was 73.7% (28.5%), con-
ﬁrming that the organisms do not recover after neutrophil death
and hence that cell-mediated reduction in luminescence does not
only reﬂect early phagocytosis (as noted earlier, dead cells do not
directly impact upon mycobacterial luminescence).
3.3. Neutrophils are not lost due to adherence to walls of
luminometer tubes
Early experiments conﬁrmed that without rocking samples
during incubation there was rapid neutrophil cell death and failure
to eliminate virulent mycobacteria, consistent with recent reports.4
However, lying tubes horizontally raised the concern that adher-
ence of neutrophils to the walls of the tubes during incubation
could lead to cells ‘sequestering’ bacilli away from the light sensor
in the luminometer. An investigator blinded to time point
measured total sample volume and performed microscopy with
counting chambers on aliquots of vortexed samples before and
after one hour’s incubation. Volumes did not decrease and, across
a range of cell densities, we did not observe any signiﬁcant
reduction in the number of neutrophils counted by one hour (mean
difference in cell count before and after incubation across four
experiments ¼ 0.4%; p ¼ 0.96).
We continued to investigate this potential issue by pipetting
away the culture medium after one hour’s incubation and replacing
with fresh medium. As demonstrated in Figure 2f, there was no
greater residual luminescence in cell-containing samples vs.
serum-only samples: again, this suggests that bacilli are not
sequestered in adherent cells.
3.4. The phagocytosis assay demonstrates clear populations of
neutrophils deﬁned by the presence and location of organisms
Figure 3aed demonstrate that when using BCG-lux, the
phagocytosis assay clearly identiﬁes cells with intracellular and
extracellular organisms. FITC positive, trypan blue negative cells
have internalised organisms only; FITC positive, trypan blue posi-
tive cells have both internal and external organisms; FITC negative,
trypan blue positive cells only possess external organisms while
dual negative cells are not associated with organisms.
3.5. Signiﬁcant clumping of organisms does not occur at lower
organism concentrations
Since mycobacteria clump in culture, we investigated whether
this phenomenon may interfere with our experiments. Samples of
FITC-labelled organisms with autologous serum in RPMI were
processed identically to cell samples from six donors and then
acquired on the ﬂow cytometer for themaximumduration taken by
a contemporaneous cell sample to reach 50,000 events.
Figure 4a shows that at high organism concentrations (5  106
RLU/1.7  106 CFU in a 500 mcl sample, the concentration used to
create MOI 3 CFU:1 cell in these experiments), clumping can be
signiﬁcant and that organisms may mimic granulocytes by forward
and side scatter. Although a cell surface marker may minimise this
problem, Figure 4b shows how a clump of organisms attached to
a cell (hence surface marker positive) may retain its green signal
even after ‘quenching’ with trypan blue. However, at lower
concentrations clumping of organisms is not a signiﬁcant problem,
with ‘granulocyte-mimicking’ organism events representing less
than 0.1 percent of true cell events (Figure 4c). Confocal imaging
conﬁrmed that at lower MOIs most neutrophils contained only one
or two bacilli (Figure 4d). We also conﬁrmed that at this concen-
tration of organisms trypan blue is able to quench FITC ﬂuorescence
and lend red ﬂuorescence to organisms (Figure 4e).
3.6. Internalisation increases with MOI, but not in a linear fashion
An analysis of multiplicity of infection is shown in Figure 5 and
Table 1. As can be seen, there was an approximately linear increase
in both internalisation and total percentage of cells which are
‘organism associated’ (i.e. those with both internalised and external
organisms) up to an MOI of 1 CFU:3 cells. After this the increase
plateaus.
At the lowest MOI (1 CFU:30 cells), there was less heterogeneity
between donors and more external binding. At the highest MOI
(3 CFU:1 cell) the forward and side scatter properties of the cells
were altered and the number of viable neutrophils counted per
50,000 events was signiﬁcantly reduced (data not shown). Use of
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Figure 2. Lysis or washing of cells results in artefactual increases in luminescence only. a. Saponin treatment permeabilises neutrophils. Samples of 400,000 neutrophils in 10%
autologous serumwere treated with 1 ml 0.1% saponin (red line) or 1 ml PBS (blue line) for 30 min and then incubated with 5 mcl propidium iodide for 20 min before acquisition on
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Figure 3. Gating strategy and interpretation for phagocytosis assay. a. First, doublet signals are excluded by plotting forward scatter area versus forward scatter height. b. Dead cells
are excluded on the basis of positivity for eFluor450 Fixable viability dye (signal seen in Paciﬁc Blue channel); note that most dead cells are also positive for trypan blue (signal seen
in APC channel). c. Neutrophils are deﬁned as positive for PE-conjugated CD66a, c, e and high side scatter. d. Neutrophils are divided into quadrants on the basis of trypan blue signal
(APC) and FITC signal (Alexa Fluor 488). Q1 (FITC positive, trypan blue negative): Internalised organisms only; Q2 (FITC positive, trypan blue positive): Internal and external
organisms; Q3 (FITC negative, trypan blue positive): External organisms only; Q4: (FITC negative, trypan blue negative): not associated with organisms.
the ﬂow cytometer. Figure shows granulocyte gate as set by forward and side scatter and propidium iodide signal (detected in PE-Cy7 channel). b. Saponin appears to increases
luminescence in cell samples, but this effect is mediated by PBS alone. 50 mcl BCG-lux (400,000 RLU (130,000 CFU)) was inoculated into either 400 mcl RPMI-1640 plus 50 mcl
autologous serum (‘serum’) or 400 mcl neutrophil suspension (MOI ¼ 1 CFU:3 neutrophils) in RPMI-1640 plus 50 mcl autologous serum (‘Cells’). After one hour’s incubation
samples were allowed to cool and either vortexed and placed immediately in the luminometer (‘immediate’) or had 1 ml 0.1% saponin added, vortexed and incubated for 30 min
before measurement in the luminometer (‘saponin’) or had 1 ml PBS added, vortexed and incubated for 30 min before measurement in the luminometer (‘PBS’). Column heights
represent mean values from four separate experiments, performed in triplicate at each occasion; error bars represent SD. p-values from paired t-tests. NS ¼ Not signiﬁcant. c. Ratio
of cell luminescence to serum luminescence does not change depending on condition. Ratio of cell:serum luminescence was calculated on samples from (b), also including
measurements on serum and cell samples immediately after the addition of PBS or saponin. p > 0.05 across all conditions. Column heights represent means, error bars represent SD.
d and e. CFU show similar pattern to RLU readings. RLU (left-hand columns, small checks), and colony forming units (right-hand columns, large checks) in 500 mcl samples
containing 10% autologous serum and the number of neutrophils as indicated on the x-axis, initially inoculated with 200,000 RLU (80,000 CFU) BCG-lux. RLU and CFU were
measured after 1 h (d) or 24 h (e) incubation at 37 C. Column heights represent means from two separate experiments, performed in triplicate for each condition; error bars
represent SD. * ¼ p < 0.05 versus serum control. Overall p-values for one-way ANOVA: 1 h RLU, 0.019; 1 h CFU, 0.019; 24 h RLU, 0.027; 24 h CFU, 0.010. Above each pair of columns is
the mean RLU:CFU ratio for that MOI and time point. f. There is no greater residual luminescence in cell versus serum samples after replacing culture medium. Samples containing
200,000 RLU (80,000 CFU) BCG-lux, 10% autologous serum and either no neutrophils (‘Serum’) or 400,000 neutrophils (‘Cells’) were incubated at 37 C for one hour. Sample
luminescence was either measured directly or culture medium was pipetted away and 500 mcl fresh RPMI-1640 added before measurement (‘Serum pipetted’ and ‘Cells pipetted’).
Results represent three separate experiments, performed in duplicate for each condition; p-values derived from paired t-tests.
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Figure 4. Assessment of clumping. a. A Forward Scatter versus Side Scatter plot of BCG-lux organisms (with 10% serum in RPMI-1640) demonstrates how organisms can mimic cells;
the granulocyte gate was derived from a contemporaneous cell sample from the donor of the serum. b. Confocal microscopy image of a clump of BCG organisms attached to
a neutrophil; note that the green ﬂuorescence of individual external organisms has been ‘quenched’ by trypan blue and they now ﬂuoresce red (arrows), while the clump of
organisms remains green. Nuclei are stained with Hoechst 33342. c. Samples of BCG-lux at different concentrations in the presence of human serum in RPMI-1640 were processed
identically to cell-containing samples and results acquired on the ﬂow cytometer. The number of events in these organism-only samples seen inside a granulocyte gate derived from
MOI of 3 CFU:1 cell was also associated with a very high FITC
median ﬂuorescence intensity (MFI) which interfered with the PE
signal of the neutrophil cell surface marker CD66a, c, e even after
compensation.
We therefore utilised an MOI of 1 CFU to 3e6 cells for optimal
results in terms of both minimising organism clumping (Figure 4)
and easily measuring internalisation. These MOIs are also suitable
for the restriction assay (see above).
We were able to repeat the assay in three of the donors, main-
taining MOI 1:3. The mean difference in percentage of neutrophils
internalisingmycobacteria between theﬁrst and second experiments
was only 1.76%, suggesting good reproducibility of the method.
3.7. Internalisation is inhibited by low temperature and results are
comparable with those using acid-resistant ﬂuorophores
As a test of the reliability of the assay, we processed matched
samples incubated at either 37 C or on ice (Supplementary
Figure 2). Ice inhibited internalisation signiﬁcantly (using MOI
0.3 CFU:1 cell, mean percentage of neutrophils with internalised
organisms at 37 C¼ 39.2%11.3%, mean percentage of neutrophils
with internalised organisms at 0 C ¼ 2.8% 3.1%, p ¼ 0.047) There
was also a trend towards greater external binding when incubated
on ice (using MOI 0.3 CFU:1 cell, mean percentage of neutrophils
with external binding at 37 C ¼ 9.9% 7.1%, mean percentage of
neutrophils with external binding at 0 C ¼ 19.4% 13.0%).
Due to concerns regarding the acid resistance of FITC, we also
compared the assay with experiments using the acid-resistant
ﬂuorophore pHrodo (Invitrogen): Supplementary Figure 3
details the experimental procedure and gating strategy. The mean
internalisation using BCG-lux and an MOI of 0.3 was 37.6% using
pHrodo versus 35.5% for our assay, and we thus consider results
to be comparable.
3.8. Trypan blue stains dead and ﬁxed cells
As mentioned above, trypan blue is commonly used in ﬂow
cytometry based phagocytosis assays to ‘quench’ extracellular
ﬂuorescence, and since it ﬂuoresces itself in the red spectrum can
be used to identify surface-bound organisms.8,10 However, trypan
blue also enters dead cells and these could therefore be inter-
preted as organism-associated events. Samples processed without
organisms showed good concordance between trypan blue and
a Fixable Viability Dye (eFluor450) in identifying dead cells: see
Figure 6aec.
Using a Viability Dye in our experimental samples excluded
amean of 1097 (407) events per sample, which represented 3.77%
(0.11%) of viable neutrophils.
We were also concerned that ﬁxed cells would become positive
for trypan blue signal. To investigate this, samples with a 1 CFU:3
cells MOI were processed again the following day. After this pro-
longed ﬁxation (17e24 h) nearly all events had become positive for
trypan blue (see Figure 6b). However, there was only limited
quenching of internalised signal: the mean percentage of FITC
positive events on the following day was 95.7% that of the imme-
diately acquired samples.
3.9. Non-heat inactivated autologous serum is optimal to
demonstrate signiﬁcant phagocytosis and mycobacterial restriction
Phagocytosis of mycobacteria by neutrophils is likely to be
inﬂuenced signiﬁcantly by opsonisation16 and we therefore inves-
tigated the need for pre-opsonisation and compared autologous
and fetal calf serum as opsonins.
Using an MOI of 1 CFU:3 cells we processed contemporaneous
samples either pre-opsonised (20 min incubation of organisms
and serum), non-pre-opsonised but with serum added at the same
time as organisms, or no serum at all. Results of internalisation
and external binding for six donors are shown in Figure 7a. There
was no signiﬁcant difference between the percentages of
neutrophils internalising organisms when pre-opsonised or when
serum was added at the same time as mycobacteria. However,
there was a highly signiﬁcant difference (p < 0.001) between
both these conditions and the percentage of neutrophils inter-
nalising organisms in the ‘no serum’ samples. There was a non-
signiﬁcant trend towards greater external binding in the
absence of serum.
Since the results of this assay reﬂect both the donor’s cellular
phagocytic capability and the extent of opsonisation we repeated
the assay, using an MOI of 1 CFU:3 cells, with stored serum from all
six donors but a single neutrophil donor. In terms of total inter-
nalisation, the coefﬁcient of variation between donors reduced
from 30.5% when using autologous neutrophils to 12.5% when
using a single neutrophil donor.
Heat inactivation of serum at 56 C reduced internalisation (by
the same single donor’s neutrophils) signiﬁcantly but not entirely:
mean value reduced from 47.7% to 7.9% of neutrophils internal-
ising. However, the coefﬁcient of variation among the heat inac-
tivated serum samples was higher than with intact serum, at
36.1%.
Use of Heat inactivated Fetal Calf Serum yielded similar results to the
‘No serum’ condition (see Figure 7b), with internalisation less than 1%.
a contemporaneous cell sample (on the basis of forward and side scatter) are here expressed as a percentage of the number of viable neutrophils in that cell sample; note the
logarithmic y-axis and hence results are not shown if they are zero. Each marker represents one donor; lines represent medians. Overall p-value for Kruskal-Wallis test ¼ 0.0028. d.
Orthogonal Confocal microscopy images conﬁrm in three dimensions that organisms (here GFP-expressing BCG-lux) are internalised and, as it typical at an MOI of 1 CFU:6 cells,
most neutrophils only contain one or two organisms. Nuclei are stained with Hoechst 33342. e. Samples of 8  104 CFU FITC-labelled BCG-lux were prepared in 1 ml PBS with 12.5
mcl trypan blue (red line) or without trypan blue (blue line), centrifuged and ﬁxed in 2% paraformaldehyde before acquisition on the ﬂow cytometer. Signal in the Alexa-Fluor 488
(FITC) and APC (trypan blue) channels is represented for both samples; trypan blue treatment results in near-total loss of FITC signal and increase in APC signal.
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Figure 5. Determining optimal multiplicity of infection to demonstrate phagocytosis.
Percentage of viable neutrophils with internalised organisms or ‘organism associated’
(includes those cells with external organisms only) according to infecting inoculum of
pre-opsonised FITC-labelled BCG-lux. The x-axis is a log10 scale, and inocula used for
these experiments are indicated. Expressed as MOI (CFU:cells), 1.7  104 CFU ¼ 1:30;
8  104 CFU ¼ 1:6; 1.7  105 CFU ¼ 1:3; 1.7  106 RLU ¼ 3:1. Markers represent mean
of six experiments, error bars represent standard deviation. Neutrophils isolated by
MicroBeads.
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Non-heat-inactivated serum was also optimal for sustaining
mycobacterial luminescence in the restriction assay, and
hence allowed maximum demonstration of neutrophil-mediated
restriction. RPMI alone signiﬁcantly reduced mycobacterial biolu-
minescence (see Supplementary Figure 4). Heat inactivation of
serum at 56 C, and even more so at 90 C, reduced mycobacterial
luminescence towards the level seen in RPMI alone, and this pattern
was maintained to 24 h. The use of Hanks’ Balanced Salt Solution
(HBSS) resulted in proportionally higher readings for all conditions
but the same pattern of results was maintained (data not shown).
4. Discussion
We have here demonstrated a novel, simple technique to assess
restriction of mycobacteria by human neutrophils, and optimised
a phagocytosis assay which can be used contemporaneously.
The restriction experiments are performed in single tubes
without transferring or disturbing the medium during analysis;
extensive evidence conﬁrms that lysis of human cells is not
required. As expected, increasing the ratio of neutrophils to
mycobacteria improves restriction on average, but there is
considerable variability depending on donor e as previously
proposed.3 This heterogeneity suggests that the technique may
prove useful in detecting important differences in innate immune
function.
Luminescent organisms carry a number of advantages for these
assays: the ability to accurately standardise inocula (vital if per-
forming cross-sectional inter-donor or prospective intra-donor
analysis), the capacity to perform high throughput experiments
with multiple replicates of experimental conditions, and instant
results. It should be noted that the ‘read-out’ in the restriction
experiments is a marker of mycobacterial metabolism and,
although there does appear to be good correlation with CFU results
(Figure 2d and e), the assay does not directly measure bacterial
numbers. Nevertheless, it is arguable that luminescence is a better
marker of overall organism ‘ﬁtness’,11 and since there is no recovery
of luminescence over 24 h despite death of the granulocytes we can
conclude that the impact on ﬁtness by neutrophils is long-lived.
Table 1
Results from the phagocytosis assay (six donors) according to multiplicity of infection.
Multiplicity of
infection
(CFU: cells)
A. Neutrophils with
internalised organisms
only (mean %  standard
deviation)
B. Neutrophils
with both internalised
and external organisms
(mean %  standard
deviation)
C. Neutrophils with
external organisms
only (mean % 
standard deviation)
D. Total with internalised
organisms (¼A. þ B.)
(mean %  standard
deviation)
E. Total with
external organisms
(¼B. þ C.) (mean % 
standard deviation)
F. Neutrophils not
associated with
organisms (mean % 
standard deviation)
0.03:1 5.32  2.45 0.68  0.24 13.05  8.06 6.01  2.58 13.73  8.15 80.96  7.15
0.15:1 20.82  11.63 1.77  0.65 7.17  3.58 22.59  12.15 8.94  3.20 70.25  8.85
0.3:1 31.07  10.91 4.47  2.33 8.51  4.34 35.54  11.24 12.98  5.08 55.93  7.50
3:1 56.42  15.11 20.05  15.85 3.98  2.61 76.47  14.62 24.03  16.50 19.57  13.54
Figure 6. Trypan blue stains dead and prolonged ﬁxed cells. aec. Concordance of eFluor450 Fixable viability dye (ﬂuorescence detected in the Paciﬁc Blue channel) and trypan blue
(ﬂuorescence detected in APC channel). Samples of 400,000 neutrophils without organisms were stained with 12.5 mcl trypan blue and 1 mcl eFluor450 Fixable viability dye only;
a e freshly isolated cells; b e cells heat-shocked at 60 C for 20 min; c e sample containing half freshly isolated and half heat-shocked cells. Plots include all singlet events. d. A
sample of neutrophils containing FITC-labelled BCG organisms was acquired immediately (blue) and the following day (red); note the shift on the trypan blue axis (APC channel) but
little change in the FITC (Alexa-Fluor 488) axis.
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Neutrophils do not of course work in isolation in the body and, as
‘ﬁrst responders’ before the arrival of other cells, a substantial
impact on mycobacterial health, rendering organisms more
susceptible to killing, may be as signiﬁcant as killing itself.
The phagocytosis assay presented here resolves a number of
issues of particular concern for experiments using mycobacteria
and neutrophils. First, if the density of organisms is too high
then clumping can be signiﬁcant enough to interfere with ﬂow
cytometric analysis. However, we have discovered that at
lower concentrations (below approximately 5  105 RLU, or 1e
2  105 CFU, in 500 mcl total volume) this issue is not signiﬁcant.
At lowerMOI it is therefore not essential to use a cell surfacemarker
to conﬁrm that a ‘granulocyte’ event, as deﬁned by forward and side
scatter, is a mammalian cell. Nevertheless, we include CD66a, c, e
-PE in our assay since it also serves as a useful marker of neutrophil
activation and degranulation.
Conversely, too low a concentration of organisms (5  104 RLU,
or 1.7  104 CFU incubated with 4  105 neutrophils in 500 mcl
volume) reduces inter-donor variability and appears to increase
external binding. This latter ﬁnding may relate to a ‘delay’ in the
neutrophils encountering the organisms.
We also investigated the correct usage of the quenching agent
trypan blue in this assay. Since neutrophils die rapidly in vitro,
a signiﬁcant percentage of cell events may be dead and hence
artefactually trypan blue positive: it is therefore essential to also
use a Viability Dye. It should be noted that the emission spectrum of
trypan blue is broad in the red and far-red spectrum. We found
similarly high MFI for trypan blue positive events among single-
stained control samples in APC, Phycoerythrin-cyanin 5.5 (PE-
Cy5.5), PE-Cy7 and Peridinin Chlorophyll Protein-Cyanin 5.5
(PerCP-Cy5.5). This necessarily limits the number of extra ﬂuoro-
chromes which can be added to the assay.
Another important aspect is the need for prolonged ﬁxation to
ensure death of organisms when using virulent mycobacteria. As
we have demonstrated, this permeabilises cells to trypan blue and
as such the phagocytosis assay cannot be effectively used to resolve
surface-bound organisms with M. tb. Importantly however,
internalised signal does remain fairly reliable.
Despite these issues, we still believe that a quenching agent is
the best solution to prove internalisation compared to other
strategies. Phagocytosis inhibitors (eg cytochalasin D) to create
a ‘negative’ control17 may not completely abolish internalisation
and may result in greater relative surface adherence; incubating
samples on ice appears to induce the same phenomenon
(Supplementary Figure 2). Use of a secondary labelling antibody to
identify mycobacteria on cell surfaces and removing these events
(9) will also remove signals from cells which have both internal-
ised and adherent organisms. Antibiotic elimination of extracel-
lular organisms is unlikely to occur rapidly enough to allow
processing of samples before neutrophil cell death, and ﬂuoro-
chrome labels can remain ﬂuorescent on dead organisms. The pH-
sensitive ﬂuorochrome pHrodo (Invitrogen) only ﬂuoresces
strongly when the pH of its micro-environment falls, consistent
with internalisation into the phagosome. However, this does not
enable resolution of surface-bound organisms, virulent mycobac-
teria may prevent deacidiﬁcation of the phagosome,18 and we
found that the labelling procedure signiﬁcantly affected viability
resulting in difﬁculty with standardising inocula and consequent
variability in the assay.
We also investigated the impact of opsonisation on neutrophil
phagocytosis of mycobacteria. Although a separate period of pre-
opsonisation was not required, serum was clearly needed to
permit internalisation (see Figure 7). Heat inactivation signiﬁ-
cantly reduced the percentage of neutrophils internalising
organisms, perhaps suggesting an important role for complement
in this regard. It was interesting to note that the assay worked
successfully using a single donor’s neutrophils but different
donors’ serum, allowing us to directly compare the opsonic
capacity of serum. Heat inactivation in this context increased the
coefﬁcient of variation signiﬁcantly, which may represent the
variable presence or activity of antibodies and could represent
another measurable outcome.
However, heat inactivated serum also resulted in impaired
mycobacterialmetabolism in the restrictionassay’s control condition
(serum þ medium only; see Supplementary Figure 4). This effect,
combined with reduced neutrophil phagocytosis, makes it more
difﬁcult to identify the anti-mycobacterial effect of the cells. Hence
for the purposes of the restriction assay and to ensuremeasurement
Figure 7. Investigation of opsonisation. a. Internalisation and external binding of FITC-
labelled BCG-lux by viable MicroBead-isolated neutrophils according to opsonisation.
All conditions performed with MOI 1 CFU:3 cells and incubated for 30 min. ‘Pre-
opsonised’ e organisms were incubated with autologous serum for 20 min at 37 C
before infection of cells. ‘Non-pre-opsonised’ e organisms and serum were added at
the same time. ‘No serum’ e organisms were added without serum. Each marker
represents one donor; lines represent means. Overall p-value for one-way
ANOVA < 0.0001. b. Plot of FITC signal in viable neutrophils from one donor incu-
bated (1 CFU:3 cells) with labelled organisms for 30 min. Blue line: organisms pre-
opsonised for 20 min with autologous serum; red line: organisms pre-opsonised for
20 min with heat inactivated fetal calf serum (contemporaneous sample).
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of appreciable internalisation in the phagocytosis assay, non-heat-
inactivated serum is preferred in most circumstances.
In summary, we have demonstrated robust and easily used
techniques to measure mycobacterial restriction and phagocytosis
of mycobacteria by human neutrophils. We believe that these
assays can be used to further explore the role of neutrophils in the
host response to tuberculosis and the impact of potential modu-
lators on neutrophil-mediated antimycobacterial activity.
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